STAAR Surgical to Participate in Upcoming Investor Conferences
07 Agosto 2023 - 8:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses for the eye, today
announced that management will participate in several upcoming
investor conferences.
STAAR management will participate in the following investor
conferences:
- Canaccord Genuity Annual Growth Conference, Wednesday, August
9. Management Presentation and Q&A at 10:00 a.m. Eastern / 7:00
a.m. Pacific at the following link:
https://wsw.com/webcast/canaccord89/staa/2452967
- Needham Virtual MedTech & Diagnostics Conference, Tuesday,
August 15
- Piper Sandler West Coast Field Trip, Wednesday, August 23
- William Blair West Coast Field Trip, Wednesday, August 30
- Goldman Sachs European Medtech and Healthcare Services
Conference, September 6
In-person attendance at the investor conferences is by
invitation only from each sponsoring brokerage firm. Please contact
each brokerage firm directly for more information.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 40 years, designs, develops, manufactures and markets
implantable lenses for the eye. These lenses are intended to
provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are
foldable, which permits the surgeon to insert them through a small
incision. STAAR’s lens used in refractive surgery is called an
Implantable Collamer® Lens or “ICL”, which includes the EVO ICL™
product line. More than 2,000,000 ICLs have been sold to date and
STAAR markets these lenses in over 75 countries. To learn more
about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230807248774/en/
Investors & Media Brian Moore Vice President,
Investor, Media Relations and Corporate Development (626) 303-7902,
Ext. 3023 bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
STAAR Surgical (NASDAQ:STAA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024